Company Filing History:
1 out of 832,880 Years Active: 2009
Title: Amarylla Horvath: Innovator in Pharmaceutical Chemistry
Introduction
Amarylla Horvath is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of compounds that have potential therapeutic applications.
Latest Patents
Horvath holds a patent for "Acylsulfonamides as inhibitors of steroid sulfatase." This patent describes a compound of formula wherein R is haloalkyl, alkenyl, phenyl, thienyl, pyridine, benzthiazolyl, chromanyl (1,2-dihydrobenzopyranyl), or (C)aryl. Additionally, R or R' independently can be substituted (C)cycloalkyl, a substituted bridged cycloalkyl system, substituted piperidine, substituted tetrahydropyridine, or a substituted bridged heterocyclic system. This compound is recognized for its utility as a pharmaceutical agent.
Career Highlights
Throughout his career, Horvath has focused on developing innovative solutions in the pharmaceutical sector. His work has led to advancements in drug development, particularly in the area of steroid sulfatase inhibition, which is crucial for various therapeutic applications.
Collaborations
Horvath has collaborated with esteemed colleagues such as Philipp Lehr and Peter Nussbaumer. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Amarylla Horvath is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the medical field significantly. His innovative patent and collaborations highlight his commitment to advancing healthcare solutions.